» Authors » Brendan Boyle

Brendan Boyle

Explore the profile of Brendan Boyle including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 60
Citations 685
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Adler J, Galanko J, Ammoury R, Benkov K, Bousvaros A, Boyle B, et al.
Am J Gastroenterol . 2024 Oct; PMID: 39423015
Objectives: HLA DQA1*05 has been associated with the development of anti-drug antibodies (ADA) to tumor necrosis factor antagonists (anti-TNF) and treatment failure among adults with Crohn's disease (CD). However, findings...
2.
Wright J, Ardura M, Dotson J, Boyle B, Maltz R, Michel H
J Pediatr Gastroenterol Nutr . 2024 Sep; 79(6):1153-1163. PMID: 39329236
Objective: Patients with inflammatory bowel disease (IBD) prescribed immunosuppressive therapies including antitumor necrosis factor (aTNF) therapies are at increased risk of histoplasmosis. We aim to evaluate the presentation, management, and...
3.
Iovino N, McClinchie M, Abdel-Rasoul M, Boyle B, Dotson J, Michel H, et al.
J Pediatr Gastroenterol Nutr . 2024 Jul; 79(4):885-894. PMID: 38946674
Objectives: Combination therapy consists of both anti-tumor necrosis factor (anti-TNF) and an immunomodulator (IMM) and has been shown to improve outcomes in patients with inflammatory bowel disease (IBD). This study...
4.
Mitchell R, Gu J, Boyle B
Health Care Manage Rev . 2024 Feb; 49(2):86-93. PMID: 38393981
Background: Organizational citizenship behavior (OCB) may increase service quality. In contrast, counterproductive work behavior (CWB) may undermine patient safety. Efforts to increase OCB and reduce CWB rely on a good...
5.
McNicol M, Abdel-Rasoul M, McClinchie M, Morris G, Boyle B, Dotson J, et al.
J Pediatr Gastroenterol Nutr . 2024 Feb; 78(3):644-652. PMID: 38334232
Objectives: The safety, efficacy, and cost savings associated with biosimilar medications are well established. However, a lack of pediatric data exists surrounding clinical outcomes when switching from an originator to...
6.
Rowland P, McNicol M, Kiel A, Maltz R, Donegan A, Dotson J, et al.
J Pediatr Gastroenterol Nutr . 2024 Jan; 78(4):853-861. PMID: 38270212
Objectives: Therapeutic drug monitoring (TDM) and dose optimization have been shown to improve clinical outcomes with antitumor necrosis factor and recent studies in adults suggest an exposure-response relationship with drug...
7.
Halliwell P, Mitchell R, Boyle B
PLoS One . 2023 Dec; 18(12):e0294953. PMID: 38055668
There has been an increasing shift towards individually owned leader development programs within organizations. Whilst leadership coaching is one of these and is gaining in popularity, the mechanisms of its...
8.
Farmer P, Boyle B, Hill I, Kiel A, Ediger T
J Pediatr . 2023 May; 259:113487. PMID: 37201683
Objective: To analyze laboratory testing results from pediatric patients newly diagnosed with celiac disease to determine the usefulness of each test derived from recommended guidelines. Methods: Serological testing at the...
9.
Hawa K, Maltz R, Donegan A, Prasad V, Dotson J, Boyle B, et al.
JPGN Rep . 2023 May; 3(4):e255. PMID: 37168479
Postcolectomy enteritis is characterized by diffuse small bowel inflammatory changes following colectomy for medically refractory ulcerative colitis. Symptoms may include abdominal pain, massive intestinal bleeding, intestinal perforation, and high stoma...
10.
Lloyd A, Ardura M, Wise K, Chavarin D, Boyle B, Sivaraman V
Front Pediatr . 2023 Mar; 11:1103096. PMID: 36937959
Background: Vaccination of immunocompromised children (ICC) remains suboptimal. Methods: Needs assessment surveys were administered to patients and caregivers during routine ambulatory visits to the rheumatology and gastroenterology clinics at Nationwide...